secwatch / observer
8-K filed March 17, 2026, 7:59 PM ET ticker DMII CIK 0002040475
debt confidence high sentiment neutral materiality 0.60

Drugs Made In America Acquisition II Corp. issues $150K convertible bridge note as part of $1.4M financing

Drugs Made In America Acquisition II Corp.

item 1.01item 8.01item 2.03item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001213900-26-029050
form_type
8-K
ticker
DMII
cik
0002040475
company_name
Drugs Made In America Acquisition II Corp.
filed_at
2026-03-17T23:59:59+00:00
discovered_at
2026-05-14T18:02:37.099623+00:00
generated_at
2026-05-15T11:06:59.533266+00:00
sec_items
["1.01", "8.01", "2.03", "9.01"]
event_type
debt
sentiment
neutral
materiality_score
0.6
calibrated_materiality_score
0.6
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001213900-26-029050
json_url
https://secwatch.observer/filing/0001213900-26-029050.json
markdown_url
https://secwatch.observer/filing/0001213900-26-029050.md
text_url
https://secwatch.observer/filing/0001213900-26-029050.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/2040475/000121390026029050/0001213900-26-029050-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/2040475/000121390026029050/ea0281959-8k_drugs2.htm
generated_by_model
deepseek-v4-flash:cloud
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

267b8676975fe9bb73cf18586014edcb01dafbde

Drugs Made In America Acquisition II Corp. incurred convertible notes of $150,000 with Alpha Multi Family Office at does not bear interest maturing nine months from the date of issuance.

On March 11, 2026, Drugs Made In America Acquisition II Corp. (the “ Company ”) issued an unsecured convertible note (the “ Bridge Note ”) to Alpha Multi Family Office (the “ Investor ”) in the principal amount of $150,000 (the “ Bridge Loan ”).

SEC 8-K Item 2.03/2.04 confidence 0.9 SEC evidence

c7df68800c0a7f4159d71d5728d9a63f8c1256bd

Drugs Made In America Acquisition II Corp. entered into Bridge Note with Alpha Multi Family Office valued at $150,000 (effective 2026-03-11).

On March 11, 2026, Drugs Made In America Acquisition II Corp. (the “ Company ”) issued an unsecured convertible note (the “ Bridge Note ”) to Alpha Multi Family Office (the “ Investor ”) in the principal amount of $150,000 (the “ Bridge Loan ”).

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

Comparable filings

BKNG

Booking Holdings issues $750M of 5.375% Senior Notes due 2036

Booking Holdings Inc. May 7, 2026, 7:59 PM ET debt Items 1.01, 2.03, 8.01, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 8.01, 9.01 same event type: debt similar materiality

This filing

On March 11, 2026, Drugs Made In America Acquisition II Corp. (the “ Company ”) issued an unsecured convertible note (the “ Bridge Note ”) to Alpha Multi Family Office (the “ Investor ”) in the principal amount of $150,000 (the “ Bridge Loan ”).

Comparable filing

in connection with the sale of $750,000,000 aggregate principal amount of the Company’s 5.375% Senior Notes due 2036

Filing page SEC filing

NWE

NorthWestern Energy subsidiary enters $225M secured term loan, repays revolver

NorthWestern Energy Group, Inc. June 2, 2026, 7:22 AM ET debt Items 1.01, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

On March 11, 2026, Drugs Made In America Acquisition II Corp. (the “ Company ”) issued an unsecured convertible note (the “ Bridge Note ”) to Alpha Multi Family Office (the “ Investor ”) in the principal amount of $150,000 (the “ Bridge Loan ”).

Comparable filing

NW Corp's obligations under the Term Loan are secured by a $225 million first mortgage bond

Filing page SEC filing

TCPC

BlackRock TCP Capital closes $535.8M CLO securitization, repays existing debt facilities

BlackRock TCP Capital Corp. June 1, 2026, 4:50 PM ET debt Items 1.01, 1.02, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

On March 11, 2026, Drugs Made In America Acquisition II Corp. (the “ Company ”) issued an unsecured convertible note (the “ Bridge Note ”) to Alpha Multi Family Office (the “ Investor ”) in the principal amount of $150,000 (the “ Bridge Loan ”).

Comparable filing

Item 1.01. Entry into a Material Definitive Agreement. On May 27, 2026 (the " Closing Date "), BlackRock TCP Capital Corp. (the " Company "), through its subsidiary, completed a $535,780,000 securitization of certain loans held by a subsidiary of the Company (the " CLO Transaction "). On the Closing Date and in connection with the CLO Transaction, BlackRock DLF 2026-C

Filing page SEC filing

EHC

Encompass Health issues $500M 5.875% notes due 2034; to redeem $400M of 4.500% notes due 2028

Encompass Health Corp June 1, 2026, 4:26 PM ET debt Items 1.01, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

On March 11, 2026, Drugs Made In America Acquisition II Corp. (the “ Company ”) issued an unsecured convertible note (the “ Bridge Note ”) to Alpha Multi Family Office (the “ Investor ”) in the principal amount of $150,000 (the “ Bridge Loan ”).

Comparable filing

On May 29, 2026, Encompass Health Corporation (the “Company”) completed the issuance and sale of $500 million in aggregate principal amount of its 5.875% Senior Notes due 2034 (the “Notes”), along with the related guarantees of the Notes by certain of the Company’s subsidiaries (the “Guarantees”), in a private offering.

Filing page SEC filing

VVX

V2X refinances $868.5M term loans with new tranche maturing 2030; SOFR+2% margin

V2X, Inc. June 1, 2026, 4:10 PM ET debt Items 1.01, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

On March 11, 2026, Drugs Made In America Acquisition II Corp. (the “ Company ”) issued an unsecured convertible note (the “ Bridge Note ”) to Alpha Multi Family Office (the “ Investor ”) in the principal amount of $150,000 (the “ Bridge Loan ”).

Comparable filing

The Amendment provides for, among other things, a new tranche of term loans under the Credit Agreement in an aggregate original principal amount of $868,522,978.38 (the “New Term Loans”), which New Term Loans replace or refinance in full all of the existing term loans outstanding under the Credit Agreement (as in effect immediately prior to the Amendment), as further set forth in the Amendment. The New Term Loans mature on December 6, 2030.

Filing page SEC filing

PFG

Principal Financial Group issues $400M of 5.300% Senior Notes due 2037

PRINCIPAL FINANCIAL GROUP INC June 1, 2026, 4:05 PM ET debt Items 1.01, 2.03, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 2.03, 8.01, 9.01 same event type: debt similar materiality

This filing

On March 11, 2026, Drugs Made In America Acquisition II Corp. (the “ Company ”) issued an unsecured convertible note (the “ Bridge Note ”) to Alpha Multi Family Office (the “ Investor ”) in the principal amount of $150,000 (the “ Bridge Loan ”).

Comparable filing

On June 1, 2026, Principal Financial Group, Inc. (the “Company”) issued $400,000,000 aggregate principal amount of its 5.300% Senior Notes due 2037 (the “Notes”). The Notes were issued pursuant to the Senior Indenture, dated as of May 21, 2009 (the “Senior Indenture”), among the Company, as issuer, Principal Financial Services, Inc. (“PFSI”), as guarantor, and The Bank of New York Mellon Trust Company, N.A., as trustee, as supplemented by the Eighteenth Supplemental Indenture, dated as of June 1, 2026 (the “Supplemental Indenture”).

Filing page SEC filing

EMAT

EMAT secures $100M convertible debenture facility from Yorkville; first $20M tranche issued

Evolution Metals & Technologies Corp. May 11, 2026, 7:59 PM ET debt Items 1.01, 2.03, 3.02, 7.01, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

On March 11, 2026, Drugs Made In America Acquisition II Corp. (the “ Company ”) issued an unsecured convertible note (the “ Bridge Note ”) to Alpha Multi Family Office (the “ Investor ”) in the principal amount of $150,000 (the “ Bridge Loan ”).

Comparable filing

The first Convertible Debenture (the “First Debenture”) in the principal amount of $20,000,000 was issued on May 7, 2026.

Filing page SEC filing

AZZ

AZZ refinances revolver; maturity extended to 2029, margins cut 50 bps

AZZ INC May 8, 2026, 7:59 PM ET debt Items 1.01, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

On March 11, 2026, Drugs Made In America Acquisition II Corp. (the “ Company ”) issued an unsecured convertible note (the “ Bridge Note ”) to Alpha Multi Family Office (the “ Investor ”) in the principal amount of $150,000 (the “ Bridge Loan ”).

Comparable filing

The Seventh Amendment (i) terminated the Initial Revolving Credit Commitments and simultaneously replaced them in their entirety with Extended Revolving Credit Commitments having a Maturity Date of May 7, 2029, (ii) decreased the interest rate margin applicable to the Revolving Credit Loans from margins ranging from 175 basis points to 275 basis points (subject to leverage ratio step-downs) to margins ranging from 125 basis points to 225 basis points (subject to leverage ratio step-downs)

Filing page SEC filing

Source: SEC EDGAR
accession 0001213900-26-029050
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.